On 4th February every year, the world commemorates the World Cancer Day. It is usually a time for raising awareness for this cancer scourge that is robbing lives indiscriminately with each passing day. To most people, the disease remains a mystery, too difficult to fathom.
Among those who work round the clock to demystify cancer is one Prof. Mikhail Blagosklonny. He is a scientist who studies cancer and aging. He also lectures Oncology at Roswell Park Cancer Institute. His research interests gravitate towards targeted cancer therapies that protect healthy cells from damage as well as the underlying mechanisms of aging and anti-aging drugs.
Blagosklonny’s career begun after he earned both his M.D. in Internal Medicine and cardiology from the Pavlov State Medical University. In 2002, he was appointed as an associate professor of medicine at New York Medical College then proceeded to being a senior scientist at Ordway Research Institute in New York. In 2009, Mikhail Blagosklonny was appointed as a professor of Oncology at Roswell Park Cancer Institute where he is based currently.
In 2006, Blagosklonny formulated a hypothesis about the possible role of Target of Rapamycin (TOR) signaling in aging and cancer. TOR integrates changes in growth factors, nutrient availability, energy status and physiological stresses. The common risk factor for most human diseases is aging, and it has been suggested that the mechanism of the link between cellular aging diseases and organismal aging is via TOR. In a nutshell, the hypothesis proposed using rapamycin, a popular cancer drug, as a possible treatment for life extension.
From his LinkedIn Profile, Blagosklonny has published more than 270 papers with over 25,000 citations in peer-reviewed journals. Besides, he is the editor-in-chief of three scientific journals which are; Aging (monthly), Cell Cycle (biweekly) and Oncotarget (weekly). Also, Mikhail serves as a member of the editorial board of a monthly academic journal, Cell Death & Differentiation.
Blagosklonny, through his lectures and numerous publications, projects a firm belief that cancer can be cured. It is this belief that makes him one of the greatest Oncology researchers in the world